• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兰索拉唑、阿莫西林和克拉霉素三联疗法用于迷走神经切断术后有消化不良症状的患者。一项随机、双盲、安慰剂对照且无预处理诊断性上消化道内镜检查的临床研究。

Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.

作者信息

Lindsetmo R O, Johnsen R, Revhaug A

机构信息

Dept. of Gastrointestinal Surgery, Tromsø University Hospital, Norway.

出版信息

Scand J Gastroenterol. 1998 Mar;33(3):231-5. doi: 10.1080/00365529850170775.

DOI:10.1080/00365529850170775
PMID:9548613
Abstract

BACKGROUND

The Maastricht Consensus Report advises that, in Helicobacter pylori-positive patients after surgery for peptic ulcer disease, H. pylori should be eradicated. The aim of the present study was to investigate the symptomatic response of H. pylori eradication in previously vagotomized peptic ulcer patients with persistent dyspeptic complaints.

METHODS

The study was performed as a randomized, double-blind, placebo-controlled study. Pretreatment diagnostic upper endoscopy was omitted. All the results were submitted to intention-to-treat and efficacy analyses.

RESULTS

We could not find any differences between the two groups with regard to intensity or frequency of upper abdominal pain, nausea, heartburn, or other abdominal symptoms during the 12-month follow-up. The triple therapy eradication rate was 88% at both 3- and 12-month controls.

CONCLUSION

Vagotomized peptic ulcer patients with persistent dyspeptic complaints should undergo a diagnostic upper endoscopy to detect ulcer recurrence before H. pylori eradication treatment is considered.

摘要

背景

《马斯特里赫特共识报告》建议,对于消化性溃疡病手术后幽门螺杆菌阳性的患者,应根除幽门螺杆菌。本研究的目的是调查在先前已行迷走神经切断术且仍有持续性消化不良症状的消化性溃疡患者中,根除幽门螺杆菌后的症状反应。

方法

本研究为随机、双盲、安慰剂对照研究。省略了治疗前的诊断性上消化道内镜检查。所有结果均进行意向性分析和疗效分析。

结果

在12个月的随访期间,两组在上腹部疼痛、恶心、烧心或其他腹部症状的强度或频率方面未发现任何差异。三联疗法在3个月和12个月时的根除率均为88%。

结论

对于有持续性消化不良症状的迷走神经切断术后消化性溃疡患者,在考虑进行幽门螺杆菌根除治疗之前,应进行诊断性上消化道内镜检查以检测溃疡复发。

相似文献

1
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.兰索拉唑、阿莫西林和克拉霉素三联疗法用于迷走神经切断术后有消化不良症状的患者。一项随机、双盲、安慰剂对照且无预处理诊断性上消化道内镜检查的临床研究。
Scand J Gastroenterol. 1998 Mar;33(3):231-5. doi: 10.1080/00365529850170775.
2
CagA status and Helicobacter pylori eradication among dyspeptic patients.消化不良患者的细胞毒素相关基因A(CagA)状态与幽门螺杆菌根除情况
Gastroenterol Hepatol. 2005 Oct;28(8):441-4. doi: 10.1157/13078993.
3
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.在日本消化性溃疡患者中,使用兰索拉唑、阿莫西林和克拉霉素三联疗法根除幽门螺杆菌的大规模多中心双盲研究的随访调查。
J Gastroenterol. 2003;38(4):339-47. doi: 10.1007/s005350300061.
4
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.三联疗法与双重疗法根除幽门螺杆菌及预防溃疡复发的比较:一项关于兰索拉唑、克拉霉素和/或阿莫西林不同给药方案的随机、双盲、多中心研究。
Am J Gastroenterol. 1998 Apr;93(4):584-90. doi: 10.1111/j.1572-0241.1998.169_b.x.
5
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.一项关于兰索拉唑、阿莫西林和克拉霉素三联疗法根除日本消化性溃疡患者幽门螺杆菌的多中心、双盲研究。
Helicobacter. 2001 Sep;6(3):254-61. doi: 10.1046/j.1523-5378.2001.00037.x.
6
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.近期基于泮托拉唑或兰索拉唑的克拉霉素联合阿莫西林治疗根除幽门螺杆菌取得成功。
Turk J Gastroenterol. 2004 Dec;15(4):219-24.
7
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?兰索拉唑、阿莫西林和克拉霉素联合用药仍可作为根除幽门螺杆菌的一线治疗方案吗?
Turk J Gastroenterol. 2005 Mar;16(1):29-33.
8
A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori.
Arch Intern Med. 1998;158(15):1651-6. doi: 10.1001/archinte.158.15.1651.
9
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].[根据质子泵抑制剂比较非溃疡性消化不良和消化性溃疡疾病患者的幽门螺杆菌根除率]
Korean J Gastroenterol. 2008 Aug;52(2):80-5.
10
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.幽门螺杆菌感染治疗对非溃疡性消化不良患者无效。奥美拉唑联合克拉霉素和阿莫西林治疗一年后效果(OCAY)研究组。
N Engl J Med. 1998 Dec 24;339(26):1875-81. doi: 10.1056/NEJM199812243392602.

引用本文的文献

1
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis.静脉注射克拉霉素对功能性消化不良和幽门螺杆菌胃炎患者消化间期胃十二指肠动力的影响。
Dig Dis Sci. 1999 Dec;44(12):2439-42. doi: 10.1023/a:1026674719476.